Cyclin D1 overexpression lacks prognostic significance in superficial urinary bladder cancer

J Pathol. 1999 May;188(1):44-50. doi: 10.1002/(SICI)1096-9896(199905)188:1<44::AID-PATH320>3.0.CO;2-Q.


The biological behaviour of urinary bladder neoplasms cannot be adequately predicted by histological criteria alone. Cyclin D1 is a cell-cycle regulating protein known to be overexpressed in a proportion of bladder carcinomas. To evaluate the prognostic significance of cyclin D1 expression and its relationship with tumour phenotype, 392 bladder carcinomas were analysed by immunohistochemistry. Clinical follow-up information was available in 337 patients with superficial bladder tumours (stages pTa/pT1). Cyclin D1 positivity was seen in 176 of 392 carcinomas. Cyclin D1 overexpression was strongly linked to papillary tumour growth, low stage, and low histological grade (p<0.005 each). Multivariate analysis showed that papillary tumour growth was the only parameter which was independently linked to cyclin D1 positivity. There was no significant difference in proliferative activity (Ki67 labelling index) between cyclin D1-negative and -positive tumours. Cyclin D1 positivity was not linked to the risk of recurrence or tumour progression, either in pTa or in pT1 carcinomas. It is concluded that cyclin D1 positivity distinguishes a large subgroup of papillary bladder tumours, but there is no evidence of prognostic significance for increased cyclin D1 expression.

MeSH terms

  • Analysis of Variance
  • Biomarkers, Tumor / analysis*
  • Carcinoma / chemistry*
  • Carcinoma / pathology
  • Cell Division
  • Chi-Square Distribution
  • Cyclin D1 / analysis*
  • Humans
  • Immunohistochemistry
  • Neoplasm Staging
  • Prognosis
  • Urinary Bladder Neoplasms / chemistry*
  • Urinary Bladder Neoplasms / pathology


  • Biomarkers, Tumor
  • Cyclin D1